Four New Clinical Trials Available at Texas Retina Associates
Our physicians remain committed to participating in ongoing retina research and providing our patients access to promising new treatment options through clinical trials. We recently opened four new clinical trials: Diabetic Macular
read more
FDA Approves First Treatment for Geographic Atrophy
On February 17, 2023, the U.S. Food and Drug Administration (FDA) approved intravitreal pegcetacoplan (brand name Syfovre), the first-ever treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Texas Retina
read more
We Love Our Patients!
At Texas Retina Associates, our patients are at the HEART of everything we do. Thank you for placing your trust in us. Happy Valentine’s Day!
read more
How Your Heart’s Health Can Affect Your Eyes
February is American Heart Month. Did you know that the same issues that can damage blood vessels in your heart can also harm the tiny blood vessels that supply blood to your
read more
Dr. Abbey Featured in New Retina Radio Podcast
Texas Retina Associates’ Ashkan M. Abbey, MD, was featured in a recently released New Retina Radio podcast for retina surgeons titled “Tips for Mastering Secondary IOLs.” Dr. Abbey discussed approaches to implanting
read more
Office Openings for 2/2/2023
All of our offices except for Mansfield will open tomorrow, February 2, 2023. However, some will open late. We will be calling all patients impacted by any closures or late openings.
read more